Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -Q1 group results

Jul 29 (Reuters)- 
             Taisho Pharmaceutical Holdings Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2019        Jun 30, 2018     Mar 31, 2020 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               60.26               61.75           293.50    
                   (-2.4 pct)          (-9.9 pct)       (+12.2 pct) 
  Operating            8.32                8.16            33.00    
                   (+2.0 pct)          (+17.5 pct)      (+5.7 pct)  
  Recurring            7.65               12.21            37.00    
                   (-37.3 pct)         (+38.8 pct)      (-9.4 pct)  
  Net                 11.01               13.69            29.50    
                   (-19.6 pct)        (+147.3 pct)      (-39.3 pct) 
  EPS              137.91 yen          171.50 yen       369.64 yen  
  EPS Diluted      137.77 yen          171.35 yen                   
  Ann Div                              120.00 yen       110.00 yen  
  -Q2 div                               50.00 yen        50.00 yen  
  -Q4 div                               70.00 yen        60.00 yen  
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news